Search the Newsreel

XERS5927663 Bond Risk Profile

This article provides an overview of the XERS5927663 bond from Xeris Biopharma Holdings, Inc., detailing its 8.0% coupon rate and a maturity date of July 15, 2028. It highlights key metrics for assessing credit risk, such as security level and issuer rating. The profile …

XERS5927663 Bond Profile — Key Metrics

This article provides a bond profile for XERS5927663, issued by Xeris Biopharma Holdings, Inc. Key details include an 8.0% coupon rate, a maturity date of July 15, 2028, and an outstanding amount of $10.57 million USD. The company, founded in 2005, is a biopharmaceutical …

Xeris Biopharma (Nasdaq: XERS) ends 8% 2028 notes via cash and stock

Xeris Biopharma Holdings, Inc. has successfully eliminated all its 8.00% Convertible Senior Notes due 2028 through a combination of privately negotiated exchanges and conversions. Approximately $23 million of notes were exchanged for 5.0 million common shares and $23 million in cash, while another $10.5 …

Xeris Pharmaceuticals appoints new director and board chair

Shareholders Will Be Pleased With The Quality of Xeris Biopharma Holdings' (NASDAQ:XERS) Earnings

Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Xeris Biopharma (XERS) Reports Q4 Earnings: What Key Metrics Have to Say

What is the current Price Target and Forecast for Xeris Pharmaceuticals (XERS)

What date does Xeris Pharmaceuticals's (XERS) report Earnings - Earnings Calendar & Announcement

Xeris Pharmaceuticals (XERS)